Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diverse pathogen and autoantigen epitopes refer to the specific molecular regions of antigens—derived from either external infectious agents or internal self-proteins—that are recognized by the adaptive immune system's B-cell and T-cell receptors (Janeway's Immunobiology, 9th ed.). Pathogen-derived epitopes are critical components in the design of vaccines and diagnostic assays, as they elicit protective immune responses against viruses, bacteria, and parasites (NCBI Bookshelf, Immunobiology). Conversely, autoantigen epitopes are the targets of aberrant immune responses in autoimmune diseases, where the immune system fails to distinguish between self and non-self (PubMed, PMID: 30236505). In a therapeutic context, these epitopes are not single targets but rather a broad class of structural motifs used to engineer immunotherapies, including monoclonal antibodies and epitope-based vaccines (Nature Reviews Drug Discovery, 2020). The diversity of these sequences necessitates precise mapping to avoid off-target effects such as cross-reactivity or the induction of unintended inflammatory cascades. Because this entry represents a diverse collection of molecular fragments rather than a single protein or receptor, it does not function as a discrete therapeutic target but rather as a category of immunological triggers.
Epitopes serve as the specific recognition sites for antibodies and T-cell receptors, triggering immune activation, neutralization of pathogens, or, in the case of autoantigens, the breakdown of self-tolerance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diverse pathogen and autoantigen epitopes.